» Articles » PMID: 32318620

Pseudodementia, Pseudo-pseudodementia, and Pseudodepression

Overview
Date 2020 Apr 23
PMID 32318620
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Dementia has a wide range of reversible causes. Well known among these is depression, though other psychiatric disorders can also impair cognition and give the appearance of neurodegenerative disease. This phenomenon has been known historically as "pseudodementia." Although this topic attracted significant interest in the 1980s and 1990s, research on the topic has waned. In this paper, we consider reasons for this decline, including objections to the term itself and controversy about its distinctness from organic dementia. We discuss limitations in the arguments put forward and existing research, which, crucially, does not support inevitable progression. We also discuss other neglected masquerades, such as of pseudodementia itself ("pseudo-pseudodementia") and depression ("pseudodepression"). Based on this reappraisal, we argue that these terms, while not replacing modern diagnostic criteria, remain relevant as they highlight unique groups of patients, potential misdiagnosis, and important, but neglected, areas of research.

Citing Articles

The different impacts of functional network centrality and connectivity on the complexity of brain signals in healthy control and first-episode drug-naïve patients with major depressive disorder.

Ji S, An W, Zhang J, Zhou C, Liu C, Yu H Brain Imaging Behav. 2024; 19(1):111-123.

PMID: 39532824 DOI: 10.1007/s11682-024-00923-5.


Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline.

Wei Y, Kung Y, Lin C, Yeh C, Chen P, Huang W Transl Psychiatry. 2024; 14(1):333.

PMID: 39152102 PMC: 11329686. DOI: 10.1038/s41398-024-03049-w.


Case report: Down syndrome regression disorder, catatonia, and psychiatric and immunomodulatory interventions.

Connors M, Sachdev P, Colebatch J, Taylor M, Trollor J, Mohan A Front Psychiatry. 2024; 15:1416736.

PMID: 39132313 PMC: 11316268. DOI: 10.3389/fpsyt.2024.1416736.


Medications for apathy in dementia.

Potter J, Baloun W, LeDrew B, Falk J Can Fam Physician. 2024; 70(6):395.

PMID: 38886087 PMC: 11280696. DOI: 10.46747/cfp.7006395.


Pseudodementia in Patients with Unipolar and Bipolar Disorders: A Case Series and Literature Review.

Elefante C, Brancati G, Acierno D, Pistolesi G, Ricciardulli S, Weiss F J Clin Med. 2024; 13(6).

PMID: 38541988 PMC: 10971625. DOI: 10.3390/jcm13061763.


References
1.
Reifler B . Arguments for abandoning the term pseudodementia. J Am Geriatr Soc. 1982; 30(10):665-8. DOI: 10.1111/j.1532-5415.1982.tb05067.x. View

2.
Herrmann L, le Masurier M, Ebmeier K . White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2007; 79(6):619-24. DOI: 10.1136/jnnp.2007.124651. View

3.
Smith J, Kiloh L . The investigation of dementia: results in 200 consecutive admissions. Lancet. 1981; 1(8224):824-7. DOI: 10.1016/s0140-6736(81)92692-1. View

4.
Butters M, Becker J, Nebes R, Zmuda M, Mulsant B, Pollock B . Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000; 157(12):1949-54. DOI: 10.1176/appi.ajp.157.12.1949. View

5.
Wells C . Pseudodementia. Am J Psychiatry. 1979; 136(7):895-900. DOI: 10.1176/ajp.136.7.895. View